ReviewArchives of toxicology2025

Outsmarting generic legislation: 4 years into the cat-and-mouse game of the synthetic cannabinoid receptor agonist market since the Chinese ban in 2021.

Marie H Deventer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.